Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 620 clinical trials
Factors Affecting the Prognosis of Early Ovarian Cancer

To elucidate factors affecting survival of early stage ovarian cancer

cancer of the ovary
ovarian cancer stage
  • 0 views
  • 24 Jan, 2021
  • 1 location
Developing a Test for the Detection of Ovarian Cancer

The study aims to develop a test for early detection of ovarian cancer using DNA from a growth involving the ovary found in a washing of the uterus (womb), and proteins found in the blood. The

  • 0 views
  • 24 Mar, 2021
  • 6 locations
Genetic Mutation in Epithelial Ovarian Cancer

Little is known about the characteristics of genetic mutation in a large multi-gene panel in epithelial ovarian cancer. This study is to explore the targeted genetic mutations via a multi-gene

platinum-based chemotherapy
adenocarcinoma
carcinoma
ovarian cancer
  • 0 views
  • 23 Jan, 2021
  • 1 location
Genomic BRCA and Extensive ovArian Cancer Testing

stage at diagnosis (stage III to IV FIGO 2014). The objective is to constitute a clinico-biological database that allows to correlate clinical and progressive features of ovarian cancer patients based

cancer of the ovary
formalin-fixed paraffin-embedded
ovarian cancer
cancer
carcinoma
  • 59 views
  • 03 Feb, 2021
  • 177 locations
Translational Analysis In Longitudinal Series of Ovarian Cancer ORganoids

This is a longitudinal observational phase II, single center, single arm study on the reliability of high grade serous ovarian carcinoma organoids obtained from primary debulking surgery (PDS

  • 0 views
  • 25 Jan, 2021
  • 1 location
Ovarian Tumor Biopsies to Study Response to Treatments

This is a research study to look at differences in tumor tissue from ovarian cancer patients that may help to determine response and resistance to treatments.

ovarian cancer
  • 1 views
  • 22 Jan, 2021
Determining Prognostic Immune Markers in Patients With Ovarian Cancer

The IMPRoVE study is a prospective, non-interventional, explorative cohort study to determine prognostic immune markers in patients with epithelial ovarian cancer, fallopian tube cancer, and

ovarian cancer
fallopian tube
primary peritoneal carcinoma
peritoneal cancer
  • 0 views
  • 10 Apr, 2021
  • 1 location
Olaparib Real-world Utilization and Clinical Outcomes in France Italy and the UK

This is a retrospective observational medical records review study of BRCA mutated advanced (FIGO stage III-IV) ovarian cancer patients who received first dose maintenance olaparib in 1L setting

cancer of the ovary
peritoneal cancer
ovarian epithelial carcinoma
platinum-based chemotherapy
olaparib
  • 0 views
  • 02 Sep, 2021
  • 21 locations
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors

This study concerns the creation of a biological collection (blood samples) in patients with Epithelial Ovarian Cancer in in order to describe the immune response with PARP inhibitors.

cancer of the ovary
ovarian epithelial carcinoma
olaparib
niraparib
  • 0 views
  • 03 Jun, 2021
  • 2 locations
Evaluation of the Predictive Value of Blood Levels of Angiopoietin 1 and Endothelial Internal Tunica Cell Kinase 2 in Patients With Ovarian Cancer Treated With Chemotherapy Associated to Bevacizumab

This is a monocentric prospective observational pilot study of translational research in women with advanced ovarian epithelial cancer. The main purpose of this study is to evaluate the predictive value of response to treatment with bevacizumab of the circulating levels of Ang1, Tie2 and VEGF before start of therapy. Secondary …

bevacizumab
cancer of the ovary
ovarian epithelial cancer
ovarian epithelial carcinoma
ovarian carcinoma
  • 0 views
  • 12 Jun, 2021
  • 1 location